Skip to main contentDoe v. GoodRx Holdings: private litigation
GoodRx’s SEC filing reports denial of preliminary approval of the amended settlement. An accrued litigation loss or proposed fund is not an approved settlement or a payment to claimants. This is separate from the FTC action.
Case record
- US District Court, Northern District of California
- CIPA, medical-information and wiretap claims
- Preliminary settlement approval denied 16 January 2026
- 16 January 2026
- 16 October 2026
What this record establishes
A settlement notice, party agreement or approval order does not establish liability after a trial. Where final approval, appeal resolution or payment is not established by the cited record, this page says so. A scheduled hearing and a proposed fund are not an award or proof of payment.
Checks for your own systems
Inth’s technical interpretation: use this case to choose what evidence to collect in your own implementation. These checks are not instructions issued by the court or regulator.
- Inspect URLs, referrers, search terms, form values and account identifiers in outgoing payloads.
- Check health, financial and authenticated surfaces separately from public pages.
- Compare browser traffic with server relays, vendor logs and the purposes described to users.
Sources and limits
Source review: 16 October 2026. This record covers the cited source and procedural stage. It does not audit the organisation’s present implementation or establish every later legal development.